Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Early breast cancer and non-chemo treatment

11th Milan Breast Cancer Conference 2009

17 - 19 Jun 2009

Published: 28 Nov 2008

Views: 3456

Rating:

Save

Professor Alan Coates

From the Milan Breast Cancer Conference.

Categories:
Breast

Related Videos

Breast-conserving therapy may be option for multiple breast lesions

Dr Judy Boughey - Mayo Clinic, Rochester, USA

Breast-conserving therapy may be option for multiple breast lesions ( Dr Judy Boughey - Mayo Clinic, Rochester, USA )

Elacestrant shows improved PFS in ER-positive/HER2-negative mBC

Dr Virginia Kaklamani - UT Health San Antonio MD Anderson Cancer Center, San Ant...

Elacestrant shows improved PFS in ER-positive/HER2-negative mBC ( Dr Virginia Kaklamani - UT Health San Antonio MD Anderson Cancer Center, San Antonio, USA )

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable a...

Dr Ian Krop - Yale Cancer Center, Connecticut, USA

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1 ( Dr Ian Krop - Yale Cancer Center, Connecticut, USA )

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did...

Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )

Comment: POLAR gene profile can identify which patients can safely avoid radiati...

Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athen...

Updates from TAILORx and RxPONDER: Implications for practice

Prof Christos Markopoulos and Dr Kevin Kalinsky

Updates from TAILORx and RxPONDER: Implications for practice ( Prof Christos Markopoulos and Dr Kevin Kalinsky )

Interruption of endocrine therapy in young breast cancer patients does not incre...

Dr Ann Partridge - Dana-Farber Cancer Institute, Boston, USA

Interruption of endocrine therapy in young breast cancer patients does not increase the risk of short-term relapse ( Dr Ann Partridge - Dana-Farber Cancer Institute, Boston, USA )

Genetic profiling identifies patients who can omit radiation therapy after breas...

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

More from ecancer